Transgene Biotek informs about standalone financial results

13 Nov 2015 Evaluate

Transgene Biotek has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

2.63 0.08 (3.14%)
19-Jan-2026 11:07 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7180.00
Max Healthcare Inst 1018.50
Narayana Hrudayalay 1886.75
Aster DM Healthcare 584.05
Global Health 1130.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×